packageLeriglitazone

leriglitazone

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Leriglitazone was investigated as a treatment for adrenoleukodystrophy. It remains investigational; a marketing application in the European Union was refused, so it is not authorised there.

Summary written by glm-5.3-flash from Wikidata Q27156475 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:leriglitazone
ATC codes:A16AX23
DrugBank:DB15021
PubChem CID:4147757
ChEBI:82937
Wikidata:Q27156475
formula:C19H20N2O4S
molar mass:372.439 g/mol (PubChem CID 4147757)
logP:2.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown